Sort
35,931 grants matching “parkinsons”
Epidemiology of Brain Aging in the Very Old
$1,557,067Kuakini Medical Center · U01 · FY2002 · AG
Advanced therapeutic for Parkinson's Disease
$1,554,563Milton H. Werner · Inhibikase Therapeutics · R44 · FY2018 · NS
Advanced therapeutic for Parkinson's Disease
$1,554,108Milton H. Werner · Inhibikase Therapeutics · R44 · FY2019 · NS
Advanced therapeutic for Parkinson's Disease
$1,554,020Milton H. Werner · Inhibikase Therapeutics · R44 · FY2017 · NS
Assessment of Candidate Loci in Neurological diseases
$1,553,712Andrew Singleton · National Institute On Aging · ZIA · FY2024 · AG
Web-based Automated Imaging Differentiation of Parkinsonism
$1,553,260David E Vaillancourt · University Of Florida · U01 · FY2021 · NS
2/2-A Comparison of Long-Acting Injectable Medications for Schizophrenia -ACLAIMS
$1,552,797Thomas Scott Stroup · Columbia University Health Sciences · R01 · FY2009 · MH
Pathologic protein folding and human disease
$1,552,667David B. Teplow · University Of California Los Angeles · P01 · FY2010 · AG
Familial Parkinson's Disease: Clues to Pathogenesis
$1,551,940Peter T Lansbury · Brigham And Women'S Hospital · P50 · FY2009 · NS
Pacific Udall Center
$1,550,974Thomas J Montine · Stanford University · P50 · FY2017 · NS
Circuit-specific, chemogenetic neuromodulation in nonhuman primates.
$1,550,458Charles E Schroeder · Nathan S. Kline Institute For Psych Res · UG3 · FY2023 · MH
Epidemiology of Brain Aging in the Very Old
$1,549,135Lon Ray White · Kuakini Medical Center · U01 · FY2007 · AG
Discovery of Multimodal Biomarkers for Parkinsonian Syndromes, Their Progression, and Pathological Relevance
$1,548,629Xuemei Huang · Pennsylvania State Univ Hershey Med Ctr · U01 · FY2022 · NS
MOLECULAR SUBSTRATES OF AGING AND NEURON DEATH
$1,548,271University Of Pennsylvania · P01 · FY2003 · AG
Neuropathology of CTE and Delayed Effects of TBI: Toward In-Vivo Diagnostics
$1,547,902Wayne A Gordon · Icahn School Of Medicine At Mount Sinai · U01 · FY2015 · NS
Pathologic protein folding and human disease
$1,547,182David B. Teplow · University Of California Los Angeles · P01 · FY2006 · AG
A Caribbean Project for Clinical and Basic Neuroscience Research
$1,547,110Edmundo Nelson Kraiselburd · University Of Puerto Rico Med Sciences · U54 · FY2010 · NS
Advanced therapeutic for Parkinson's Disease
$1,546,730Milton H. Werner · Inhibikase Therapeutics · R44 · FY2020 · NS
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
$1,546,147Judith Richmon Walters · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
Single molecule studies of protein binding and aggregation
$1,544,779Hoi Sung Chung · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Stanford Alzheimer's Disease Research Center
$1,543,943Victor W. Henderson · Stanford University · P50 · FY2016 · AG
Functional Genomics Laboratory (FGL)
$1,542,975Anton Simeonov · National Center For Advancing Translational Sciences · ZIC · FY2023 · TR
Quantifying the contributions of mitochondrial DNA to Alzheimer's Disease and related conditions of aging
$1,542,903S. Alexandra Burt · Michigan State University · RF1 · FY2021 · AG
Neural correlates for cortical and subcortical control of vocalization
$1,542,520Shahriar Sheikhbahaei · National Institute Of Neurological Disorders And Stroke · ZIA · FY2023 · NS
iPSC-based Model to Study Frontotemporal Dementia Due to MAPT Mutation
$1,540,579Sally Temple · Regenerative Research Foundation · RF1 · FY2025 · NS